Delivery Order SPE2DB22D9239-SPE2DB24FDM31

Award Date 9/9/24
Potential Completion Date 9/30/24
Potential Value $96K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. government, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $96,262.08 firm fixed-price delivery order is for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a specialty oncology medication. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $40,109.20, is a firm fixed-price delivery order for Keytruda 100 mg/4 ml vials. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that runs through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $46,536.96 firm fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vial, with an ultimate completion date of October 7, 2024. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the DLA to issue firm...
This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $96,342.84, is a firm fixed-price delivery order for the supply of Keytruda 100 mg/4 ml vials. The award is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that runs through December 31, 2025. This single-award IDC,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,947.80 firm fixed-price contract is for the supply of Keytruda 100 mg/4 ml vials to support the medical needs of military healthcare facilities. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $77,505.20 firm fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vials to support the medical needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $77,505.20 firm fixed-price delivery order is for Keytruda 100 mg/4 ml vials, a specialized oncology medication. The contract is not associated with any set-aside designation. It is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $98,449.80 firm fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vial 4 ml, a cancer treatment drug. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,947.80 firm fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vials to support the recurring medical needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Firm Fixed Price Delivery Order valued at $77,626.40 with a completion date of February 22, 2023. The contract covers the supply of Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities worldwide. This award is part of a larger...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDM31
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $96,262.08 firm fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vial, a cancer medication, with a period of performance through September 30, 2024.

The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 12/9/24, 1:43 PM